In the final episode of our series on CGM technology, Ginger Vieira explores the future directions for CGM in high-risk pregnancy care with Dr Claire Meek.They discuss:High-Risk Pregnancies and Current Gaps in CareChallenges in Type 2 Diabetes ResearchImpact of CGM Technology During PregnancyPre-Pregnancy and Pregnancy Care for Type 2 DiabetesThird Trimester and Delivery ConsiderationsEarly Adoption of Hybrid Closed LoopsDr Claire Meek is a Professor of Chemical Pathology & Diabetes in Pregnancy at the University of Leicester in the UK. She’s also an Honorary Consultant Chemical Pathologist & Metabolic Physician at the Addenbrooke’s Hospital.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
--------
20:54
--------
20:54
Postpartum CGM management and diabetes risk
In this episode, Ginger Vieira looks at postpartum CGM management, diabetes risk, and what clinicians can do to support women during this significant life event.She is joined by Dr Grenye O’Malley.They discuss:How glucose patterns and insulin needs change postpartumGDM as a spectrum to Type 2 diabetesCGM use for early detection of type 2 diabetes after GDMStrategies for transitioning from intensive pregnancy care to postpartum follow-upGrenye O'Malley is an Associate Professor in the Division of Endocrinology, Diabetes and Bone Diseases at the Icahn School of Medicine at Mount Sinai. She has research interests in the use of diabetes technologies focusing on health disparities and management of diabetes during pregnancy.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
--------
22:42
--------
22:42
Common pitfalls and troubleshooting CGM use during pregnancy
In this episode, Ginger Vieira explores the common pitfalls of CGM use in pregnancy with Dr Sarit Polsky.They discuss:Common barriers to successful CGM use in pregnancy, including skin issues and alarm fatiguePractical troubleshooting strategies for clinicians and patientsThe role of education and support in overcoming CGM-related challengesSarit Polsky is an Associate Professor of Medicine and Pediatrics at the University of Colorado, where she is the Director of the Pregnancy and Women’s Health Clinic. She is the Research Director of the Adult Clinic at the Barbara Davis Center for Diabetes and the co-Director of the American College of Diabetology Annual Conference.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
--------
18:12
--------
18:12
CGM research and trends in pregnancy
In this episode, Ginger Vieira looks at the latest technology in CGM and what it means for diabetes care during pregnancy.She is joined by Dr Denice Feig to discuss the latest research and trends in CGM during pregnancy.They discuss:How CGM improves maternal and neonatal outcomesKey clinical trials including the CONCEPTT trialEvolving trends in CGM use across different types of diabetes in pregnancy (T1D, T2D, GDM)Dr Denice Feig is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Toronto. She is a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute and an Adjunct Scientist at ICES. Dr Feig is also the Head of Diabetes and Endocrinology in the Pregnancy Program at Mount Sinai Hospital.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
--------
16:00
--------
16:00
The Future of AI-Driven CGM in Diabetes & Metabolic Health
In this episode, Dr David Kerr continues his look at AI-driven CGM tools and the future of diabetes and metabolic health. He’s joined by Stanford W. Ascherman Professor of Genetics, Dr Michael Snyder to hear the latest on emerging technologies, and the shift towards integrative and personalised healthcare.They discuss:How AI and CGM technology is transforming diabetes and metabolic health managementAI identification of diabetes subtypes and personalised interventionsImpact of physical activity, sleep, and stress on glucose levels, as well as the emerging role of gut microbiome health in metabolic wellnessPotential of AI-driven tools for early intervention and improved health outcomesDr Snyder is the Stanford W. Ascherman Professor of Genetics and Director at the Stanford Center of Genomics and Personalized Medicine. He is a leader in the field of functional genomics and proteomics, and co-founder of many biotechnology companies, including Personalis, SensOmics, Qbio @qbioinc, January AI, Filtricine, Mirvie, and Protos.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
Over ATTD: Advanced Technologies and Treatments for Diabetes
ATTD is the ultimate forum for the latest in diabetes research, technology, and clinical innovation. This podcast channel offers two types of content designed for healthcare professionals:
* ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions at the ATTD Conference.
* Curated Series: In-depth, human-led conversations such as our CGM in Focus series, supported by Dexcom, and previously Long-Acting Insulin Uncovered supported by Eli Lilly and Company.
Whether you're a specialist, researcher, or industry leader, hit subscribe.
Luister naar ATTD: Advanced Technologies and Treatments for Diabetes, We zijn toch niet gek? en vele andere podcasts van over de hele wereld met de radio.net-app
Netherlands